Loading clinical trials...

Medication Reconciliation in Hospitalized CKD Patients : A Quasi-Experimental Study | Clinical Trials | Clareo Health

COMPLETEDNA

Medication Reconciliation in Hospitalized CKD Patients : A Quasi-Experimental Study

The Impact of Medication Reconciliation on Discrepancies and All-cause Readmission Among Hospitalized Patients With Chronic Kidney Disease: A Quasi-experimental Study

NCT06819527•Jordan University of Science and Technology

View on ClinicalTrials.gov

Summary

This study aimed to evaluate the impact of combining medication reconciliation with medication review on reducing medication discrepancies at discharge and all-cause readmissions among CKD patients, in comparison to a retrospective control group that received usual care, which may or may not have included medication reconciliation.

Eligibility

Age

18 - 100 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Adult (18 years or older) admitted patients with CKD (stages 2-5 ), who were using at least three chronic medicines at home, and were hospitalized for at least 48 hours.

Exclusion Criteria

•Patients with kidney transplantation .
•Patients who have difficulties in responding to interviews and did not have family member or caregiver on behave.
•Patients who refused to provide a written informed consent.

Locations (1)

King Abdullah University Hospital and Princess Basma Hospital

Irbid, Jordan

Key Dates

Start Date

February 1, 2023

Primary Completion Date

August 30, 2023

Completion Date

August 30, 2023

Last Updated

January 29, 2026

Enrollment

323

ACTUAL participants

Conditions

Chronic Kidney Disease(CKD)

Interventions

Medication reconciliation service

OTHER

Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease

NCT05732727

Chronic Kidney Disease(CKD)Uncontrolled Hypertension

View study

RECRUITING

Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease

NCT06694558

Chronic Kidney Disease(CKD)Type 1 Diabetes (T1D)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 29, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Medication Reconciliation in Hospitalized CKD Patients : A Quasi-Experimental Study

Inclusion Criteria

Exclusion Criteria

Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease

Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease

Transcutaneous Laser Therapy in Chronic Kidney Disease

Prevalence and Severity of Cramps in Chronic Kidney Disease Patients

Multi-parametric Functional MRI in Patients of Chronic Kidney Disease

Long-term Effects of the New Nordic Renal Diet in Patients With Moderate Chronic Kidney Disease